首页> 美国卫生研究院文献>Neuro-Oncology >INNV-11. THE RISK OF HEMORRHAGE ASSOCIATED WITH THROMBOCYTOPENIA IN PATIENTS UNDERGOING OMMAYA RESERVOIR PLACEMENT FOR INTRATHECAL CHEMOTHERAPY: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
【2h】

INNV-11. THE RISK OF HEMORRHAGE ASSOCIATED WITH THROMBOCYTOPENIA IN PATIENTS UNDERGOING OMMAYA RESERVOIR PLACEMENT FOR INTRATHECAL CHEMOTHERAPY: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

机译:Innv-​​11。与血小板减少症相关的出血风险与鞘内化疗进行OMMAYA水库患者的患者:单一机构回顾性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Ommaya reservoirs are frequently inserted in patients requiring regular delivery of intrathecal medications. The incidence of intracranial hemorrhage following insertion ranges from 1–3% and is typically associated with thrombocytopenia. However, the exact platelet count at which it is considered safe to insert an Ommaya reservoir has not been previously reported. The purpose of this study is to investigate the nature of the relationship between thrombocytopenia and post-operative hemorrhage following insertion of Ommaya reservoirs for intrathecal chemotherapy.
机译:OMMAYA水库经常插入需要定期交付鞘内药物的患者。插入后颅内出血的发生率范围为1-3%,通常与血小板减少症相关。然而,先前尚未报告将其被认为安全插入OMMADA水库的精确血小板计数。本研究的目的是探讨血小板减少症和术后出血之间的性质,然后插入OmmaNA储层进行鞘内化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号